Home » Topics » BioWorld Science

BioWorld Science
RSS

Shanghai Dongxi Zhihui Biological Medicine patents beta-amyloid production inhibitors

Aug. 30, 2019

New antifilarials CBR-417 and CBR-490 validated in models in vivo

Aug. 30, 2019

Denali Therapeutics synthesizes brain-penetrant LRRK2 kinase inhibitors for the treatment of PD

Aug. 30, 2019

Mirati Therapeutics compounds target the PRC2 EED binding site

Aug. 30, 2019

La Jolla Pharmaceutical receives European approval for Giapreza

Aug. 30, 2019

Immatics and Celgene collaborate to develop novel adoptive cell therapies

Aug. 30, 2019

First patient enrolled in phase IIa study of sepranolone

Aug. 30, 2019

FDA accepts IND for clinical study of MR-301 for severe traumatic brain injury

Aug. 30, 2019

Pulmonary mucormycosis mouse model developed to test treatments

Aug. 30, 2019

Discovery of a targeted covalent CDK14 inhibitor with a TAIRE kinase-biased selectivity profile

Aug. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...